Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
HUMA
ICCC
Add up to 3 more stocks
HUMA
Humacyte, Inc.
-4.40%
$0.48-0.02Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$80.30M
52W Range
$0.48 - $1.97
ICCC
ImmuCell Corporation
+2.26%
$9.97+0.22Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$90.20M
52W Range
$4.52 - $12.10
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 117.85 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.57 | 2.87 |
| P/S Ratio | 37.86 | 2.94 |
| P/FCF Ratio | N/A | 21.40 |
| EV/EBITDA | N/A | 15.00 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | -736.5% | 40.3% |
| Operating Margin | -5271.7% | 12.6% |
| Net Margin | -4560.8% | 2.6% |
| ROE | -309.4% | 2.5% |
| ROA | -70.0% | 1.7% |
| ROIC | -90.3% | 8.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 6.21 | 4.75 |
| Quick Ratio | 5.74 | 2.71 |
| Debt/Equity | 2.12 | 0.40 |
| Interest Coverage | -9.55 | 3.76 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.